已收盘 01-23 16:00:00 美东时间
-1.080
-9.60%
Cathie Wood’s ARK Invest (ARKK) deepened investment in AI chipmakers, gene-editing companies, and autonomous-driving developers while continuing to trim positions in Tesla (TSLA) and several mature te...
01-19 20:35
New NeXT Personal® extension empowers clinicians to identify emerging resistance and therapeutically targetable mutations during disease monitoring and surveillance
01-13 05:02
Cathie Wood’s ARK Invest repositions toward long-term innovation themes like advanced air mobility, autonomous transport, and gene editing during the last week, while reducing exposure to more matur...
01-12 20:30
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
BTIG analyst Mark Massaro reiterates Personalis (NASDAQ:PSNL) with a Buy and maintains $12 price target.
01-09 18:26
Personalis shares are trading lower. The company reported Q4 and FY25 prelimina...
01-09 02:00
Clinical test volume surged 41% in Q4 over Q3 to 6,183 tests; full year volume of 16,233 tests outperforms initial 2025 projectionsStrong cash position of approximately $240 million provides capital for commercial
01-09 01:55
Personalis (PSNL) announced on Thursday that its total revenue is expected to be in the range of $69M to $70M, versus a consensus of $69.96M, compared with $84.6M for 2024. The firm said its clinical ...
01-08 21:28
2026年美股该如何操作?“木头姐”最新战略揭晓:押注基因编辑,抛售消费科技,特斯拉仍为最大持仓!布局详情>>
01-05 23:59